↓ Skip to main content

Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study

Overview of attention for article published in Frontiers in Pharmacology, December 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
9 Mendeley